March 22, 2012
An Illinois federal judge ruled Thursday that a Genzyme Corp. patent covering kidney disease treatment Hectorol is valid and enforceable in the drugmaker's suit against Cobrek Pharmaceuticals Inc. over a generic version of a renal drug that Cobrek had conceded infringing.
September 20, 2010
A federal judge has dismissed one inequitable conduct defense asserted by Cobrek Pharmaceuticals Inc. in a patent infringement suit brought by Genzyme Corp. over kidney disease treatment Hectorol, but left two other inequitable conduct defenses intact.